G1 THERAPEUTICS, INC.

Organization

RESEARCH TRIANGLE PARK, NC, US

Ticker Symbols

NASDAQ:GTHX

PHARMACEUTICAL PREPARATIONS
Business Address
79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
Mailing Address
P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
State Location
NC
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Morphic forms of trilaciclib and methods of manufacture thereof
- Patent number 12,168,666
- Issue date Dec 17, 2024
- G1 Therapeutics, Inc.
- Stephen Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Morphic forms of G1T38 and methods of manufacture thereof
- Patent number 12,139,494
- Issue date Nov 12, 2024
- G1 Therapeutics, Inc.
- Alexander Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Transient protection of normal cells during chemotherapy
- Patent number 11,717,523
- Issue date Aug 8, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of 1,4-diazaspiro[5.5]undecan-3-one
- Patent number 11,708,337
- Issue date Jul 25, 2023
- G1 Therapeutics, Inc.
- Stephen E. Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HSPC-sparing treatments for RB-positive abnormal cellular prolifera...
- Patent number 11,654,148
- Issue date May 23, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 1′,2′-dihydro-3′H-spiro[cyclohexane-1,4′-pyrimido[5′,4′...
- Patent number 11,643,416
- Issue date May 9, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
- Patent number 11,629,150
- Issue date Apr 18, 2023
- G1 Therapeutics, Inc.
- Alexander Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Preservation of immune response during chemotherapy regimens
- Patent number 11,529,352
- Issue date Dec 20, 2022
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...
- Patent number 11,446,295
- Issue date Sep 20, 2022
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of EGFR-driven cancer with fewer side effects
- Patent number 11,395,821
- Issue date Jul 26, 2022
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy for treatment of cancer
- Patent number 11,364,222
- Issue date Jun 21, 2022
- G1 Therapeutics, Inc.
- Jay C. Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
G1T38 superior dosage regimes
- Patent number 11,357,779
- Issue date Jun 14, 2022
- G1 Therapeutics, Inc.
- Andrew Beelen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of Rb-negative tumors using topoisomerase inhibitors in c...
- Patent number 11,090,306
- Issue date Aug 17, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transient protection of normal cells during chemotherapy
- Patent number 11,040,042
- Issue date Jun 22, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Morphic forms of trilaciclib and methods of manufacture thereof
- Patent number 10,988,479
- Issue date Apr 27, 2021
- G1 Therapeutics, Inc.
- Stephen Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzothiophene estrogen receptor modulators
- Patent number 10,981,887
- Issue date Apr 20, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transient protection of normal cells during chemotherapy
- Patent number 10,966,984
- Issue date Apr 6, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HSPC-sparing treatments for RB-positive abnormal cellular prolifera...
- Patent number 10,925,878
- Issue date Feb 23, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
- Patent number 10,865,210
- Issue date Dec 15, 2020
- G1 Therapeutics, Inc.
- Alexander Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Highly active anti-neoplastic and anti-proliferative agents
- Patent number 10,709,711
- Issue date Jul 14, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK inhibitors
- Patent number 10,696,682
- Issue date Jun 30, 2020
- G1 Therapeutics, Inc.
- Francis X. Tavares
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiproliferative pyrimidine-based compounds
- Patent number 10,654,831
- Issue date May 19, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzothiophene estrogen receptor modulators
- Patent number 10,633,362
- Issue date Apr 28, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidine-based compounds for the treatment of cancer
- Patent number 10,618,905
- Issue date Apr 14, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HSPC-sparing treatments for Rb-positive abnormal cellular prolifera...
- Patent number 10,434,104
- Issue date Oct 8, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of Rb-negative tumors using topoisomerase with cyclin dep...
- Patent number 10,413,547
- Issue date Sep 17, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic lactams for use in HSPC-sparing treatments for Rb-positiv...
- Patent number 10,376,519
- Issue date Aug 13, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzothiophene estrogen receptor modulators
- Patent number 10,208,011
- Issue date Feb 19, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK inhibitors
- Patent number 10,189,851
- Issue date Jan 29, 2019
- G1 Therapeutics, Inc.
- Francis X. Tavares
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK inhibitors
- Patent number 10,189,849
- Issue date Jan 29, 2019
- G1 Therapeutics, Inc.
- Francis X. Tavares
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Synthesis of 1,4-Diazaspiro[5.5]Undecan-3-One
- Publication number 20240199556
- Publication date Jun 20, 2024
- G1 Therapeutics, Inc.
- Stephen E. Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF M...
- Publication number 20240150369
- Publication date May 9, 2024
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION TREATMENTS IN DIFFICULT TO TREAT PATIENTS WITH ADVANCED...
- Publication number 20240139196
- Publication date May 2, 2024
- G1 Therapeutics, Inc.
- Andrew Beelen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK INHIBITORS
- Publication number 20240109906
- Publication date Apr 4, 2024
- G1 Therapeutics, Inc.
- Francis X. Tavares
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY
- Publication number 20230381189
- Publication date Nov 30, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERA...
- Publication number 20230364098
- Publication date Nov 16, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRESERVATION OF IMMUNE RESPONSE DURING CHEMOTHERAPY REGIMENS
- Publication number 20230302001
- Publication date Sep 28, 2023
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS
- Publication number 20230248733
- Publication date Aug 10, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIB...
- Publication number 20230241059
- Publication date Aug 3, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
G1T38 SUPERIOR DOSAGE REGIMES
- Publication number 20230149406
- Publication date May 18, 2023
- G1 Therapeutics, Inc.
- Andrew Beelen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of EGFR-Driven Cancer with Fewer Side Effects
- Publication number 20230146638
- Publication date May 11, 2023
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOF
- Publication number 20230043305
- Publication date Feb 9, 2023
- G1 Therapeutics, Inc.
- Alexander Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF M...
- Publication number 20220306644
- Publication date Sep 29, 2022
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED TREATMENT OF CANCERS WITH DYSREGULATED FIBROBLAST GROWTH F...
- Publication number 20220241275
- Publication date Aug 4, 2022
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PATIENT SELECTION FOR ENHANCEMENT OF ANTI-TUMOR IMMUNITY IN CANCER...
- Publication number 20220175787
- Publication date Jun 9, 2022
- G1 Therapeutics Inc.
- Patrick Joseph Roberts
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...
- Publication number 20220175780
- Publication date Jun 9, 2022
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK INHIBITORS
- Publication number 20210395259
- Publication date Dec 23, 2021
- G1 Therapeutics, Inc.
- Francis X. Tavares
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF
- Publication number 20210387993
- Publication date Dec 16, 2021
- G1 Therapeutics, Inc.
- Stephen Schneider
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY
- Publication number 20210299130
- Publication date Sep 30, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC REGIMENS FOR TREATMENT OF CANCER USING ERIBULIN AND SEL...
- Publication number 20210267986
- Publication date Sep 2, 2021
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERA...
- Publication number 20210213022
- Publication date Jul 15, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SYNTHESIS OF 1,4-DIAZASPIRO[5.5]UNDECAN-3-ONE
- Publication number 20210179567
- Publication date Jun 17, 2021
- G1 Therapeutics, Inc.
- Stephen E. Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS
- Publication number 20210171554
- Publication date Jun 10, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINES
- Publication number 20210122755
- Publication date Apr 29, 2021
- G1 Therapeutics, Inc.
- Alexander Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGA...
- Publication number 20210077498
- Publication date Mar 18, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINE-BASED ANTIPROLIFERATIVE AGENTS
- Publication number 20210047328
- Publication date Feb 18, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCERS HAVING DRIVING ONCOGENIC MUTATIONS
- Publication number 20210030758
- Publication date Feb 4, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
G1T38 SUPERIOR DOSAGE REGIMES
- Publication number 20200405721
- Publication date Dec 31, 2020
- G1 Therapeutics, Inc.
- Andrew Beelen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY
- Publication number 20200345742
- Publication date Nov 5, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS
- Publication number 20200345743
- Publication date Nov 5, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
90542027 - G1 TO ONE
- Serial number 90542027
- Registration number 6798909
- Filing date Feb 23, 2021
- G1 Therapeutics, Inc.
- 36 - Insurance
Information Trademark
90542030 - G1 TO ONE
- Serial number 90542030
- Registration number 6798910
- Filing date Feb 23, 2021
- G1 Therapeutics, Inc.
- 36 - Insurance
Information Trademark
90483774 - G1 THERAPEUTICS
- Serial number 90483774
- Registration number 6847724
- Filing date Jan 22, 2021
- G1 Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90483777 - G1 THERAPEUTICS
- Serial number 90483777
- Registration number 6847725
- Filing date Jan 22, 2021
- G1 Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90455982 - COSELA
- Serial number 90455982
- Registration number 6847686
- Filing date Jan 8, 2021
- G1 Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90455987 - COSELA
- Serial number 90455987
- Registration number 6726188
- Filing date Jan 8, 2021
- G1 Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations

G1 THERAPEUTICS, INC.

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Morphic forms of trilaciclib and methods of manufacture thereof

Morphic forms of G1T38 and methods of manufacture thereof

Transient protection of normal cells during chemotherapy

Synthesis of 1,4-diazaspiro[5.5]undecan-3-one

HSPC-sparing treatments for RB-positive abnormal cellular prolifera...

Substituted 1′,2′-dihydro-3′H-spiro[cyclohexane-1,4′-pyrimido[5′,4′...

Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines

Preservation of immune response during chemotherapy regimens

Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...

Treatment of EGFR-driven cancer with fewer side effects

Combination therapy for treatment of cancer

G1T38 superior dosage regimes

Treatment of Rb-negative tumors using topoisomerase inhibitors in c...

Transient protection of normal cells during chemotherapy

Morphic forms of trilaciclib and methods of manufacture thereof

Benzothiophene estrogen receptor modulators

Transient protection of normal cells during chemotherapy

HSPC-sparing treatments for RB-positive abnormal cellular prolifera...

Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines

Highly active anti-neoplastic and anti-proliferative agents

CDK inhibitors

Antiproliferative pyrimidine-based compounds

Benzothiophene estrogen receptor modulators

Pyrimidine-based compounds for the treatment of cancer

HSPC-sparing treatments for Rb-positive abnormal cellular prolifera...

Treatment of Rb-negative tumors using topoisomerase with cyclin dep...

Tricyclic lactams for use in HSPC-sparing treatments for Rb-positiv...

Benzothiophene estrogen receptor modulators

CDK inhibitors

CDK inhibitors

Patents Applicationslast 30 patents

Synthesis of 1,4-Diazaspiro[5.5]Undecan-3-One

CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF M...

COMBINATION TREATMENTS IN DIFFICULT TO TREAT PATIENTS WITH ADVANCED...

CDK INHIBITORS

TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY

HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERA...

PRESERVATION OF IMMUNE RESPONSE DURING CHEMOTHERAPY REGIMENS

HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS

ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIB...

G1T38 SUPERIOR DOSAGE REGIMES

Treatment of EGFR-Driven Cancer with Fewer Side Effects

MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOF

CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF M...

TARGETED TREATMENT OF CANCERS WITH DYSREGULATED FIBROBLAST GROWTH F...

PATIENT SELECTION FOR ENHANCEMENT OF ANTI-TUMOR IMMUNITY IN CANCER...

TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...

CDK INHIBITORS

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY

THERAPEUTIC REGIMENS FOR TREATMENT OF CANCER USING ERIBULIN AND SEL...

HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERA...

SYNTHESIS OF 1,4-DIAZASPIRO[5.5]UNDECAN-3-ONE

BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS

SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINES

TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGA...

PYRIMIDINE-BASED ANTIPROLIFERATIVE AGENTS

TREATMENT OF CANCERS HAVING DRIVING ONCOGENIC MUTATIONS

G1T38 SUPERIOR DOSAGE REGIMES

TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY

HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS

Trademarklast 30 trademarks

90542027 - G1 TO ONE

90542030 - G1 TO ONE

90483774 - G1 THERAPEUTICS

90483777 - G1 THERAPEUTICS

90455982 - COSELA

90455987 - COSELA